Eli Lilly’s Drug Offers Hope in Slowing Early-Stage Alzheimer’s Disease by up to 60%
Written by Amal Allam, Tuesday, July 18, 2023 04:31 PM Scientists hail Eli Lilly’s drug that slows early-stage disease by up to 60% as a ‘defining moment’ in dementia research Second treatment after lecanemab to offer hope to patients with the disease could be available to millions of Americans in just 18 months , according … Read more